See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.86▲ 1.40%

Globe Life Inc. (GL)

Financials · Life & Health Insurance · US stock · S&P 500 component
$168.41 ▼ -1.21 (0.71%)
At close · USD · Volume 1,736,006
Compare with MET
Fair valueFair
$150 −11.2% to fair value
$75fair band $127–$181$224
Day's range
$161.52 – $168.60
52-week range
$127.85 – $191.55

About Globe Life Inc.

Globe Life is an insurance holding company that sells life and supplemental health insurance mainly to middle-income households in the United States. It reaches customers through direct-to-consumer marketing, agencies and employer or association channels. Revenue comes from premiums paid by policyholders and from investment income earned on the assets backing its policy obligations, so claims experience and investment returns shape its results.

Trailing twelve-month revenue stands at $6.2 billion. Revenue growth over three years averaged 4.7% a year. Operating margin is 26.4% and return on invested capital is 15%. It pays a dividend with a yield of 0.7%. The X-Ray Score is 49 out of 100. These figures describe past results as reported and are a factual snapshot, not a forecast. Some measures, such as margins for real estate trusts and banks, are defined differently from those of industrial firms, so comparisons should be made with care.

52-wk range $127.85 – $191.55Volume 1,736,006Daily, split-adjusted

Vitals

Market cap$13.3B
52-week range$127.85 – $191.55
Volume (last day)1,736,006
P/E (TTM)11.2
EBIT / EV yield10.4%
Free-cash-flow yield9.3%
Dividend yield0.7%
Revenue (TTM)$6.2B
Net income (TTM)$1.2B
Operating margin26.4%
Return on capital15.3%
Debt incl. leases$2.9B
Cash & securities$455M
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies that hold large long-term investments). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.

Fair value estimate

$150middle half of models $138 – $167
Fair −11.2% to fair value
Average of the 4 valuation models that pass our checks: multiples, discounted cash flow, dividend discount and earnings power value. A model more than 100% above or 60% below the price is left out as unrealistic. Model uncertainty is Medium, based on how far apart the models are. Undervalued or Overvalued means the gap to fair value is more than 17.5%.
Price $168
Undervalued < $127Fair $127 – $181Overvalued > $181
P/E multiple
$166
P/B multiple
$171
P/S multiple
$146
Dividend discount, stable · not used
$60
Dividend discount, multi-stage
$115
A model estimate, not a price target or recommendation. Inputs: risk-free 5.13%, equity risk premium 4.30% (Damodaran). How it works.

What this means

Average business, fairly priced

The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.

Before you invest · decision checklist

Ticked boxes are filled in from our data; the rest are yours to answer.

The five-lens scan

Every score explained in one sentence, ranked against Financials peers. Open a lens to see the numbers behind it.

Strong: 70 to 100Fair: 50 to 69Weak: under 50No score: not enough data

Valuation Weak
42/100
Expensive against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield10.4%
Free-cash-flow yield9.3%
Fair value vs price0.9×
Growth Weak
42/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)4.7%
EPS growth (3y)15.9%
Growth consistency100%
Profitability Fair
58/100
Returns on capital are typical for its sector.
See the numbers →
Return on invested capital15.3%
Operating margin26.4%
Financial health Fair
51/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score8 / 9
Net debt / EBITDA1.5×
Interest cover11.6×
Dividends Weak
48/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield0.7%
Dividends vs free cash flow8%
Dividend growth2.2%

Quarterly results: last 6 quarters

+4.5%
Mar '25
+2.8%
Jun '25
+4.0%
Sep '25
+3.6%
Dec '25
+5.3%
Mar '26
+8.0%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $1.6B, diluted EPS $3.65.

Compare with peers

MET Metlife Inc56 PFH Prudential Financial I...55 PFG Principal Financial Gr...37 AFL Aflac Inc35
Other Life & Health Insurance companies by X-Ray Score.

SWOT analysis: Globe Life Inc.

Strengthsinside the company
  • Operating margin of 26.4% is well above the 8.3% median of industry peers, a sign of pricing power or lower costs.
  • Earnings per share have compounded at 15.9% a year over three years.
  • Free cash flow equals 9.3% of the market value, which funds dividends, buybacks or debt paydown.
  • Passes 8 of the 9 Piotroski tests, which points to improving profitability, funding and efficiency.
Weaknessesinside the company
  • No clear weakness in the figures we track.
Opportunitiesvaluation and setting
  • Trades at 11.0x earnings, 21% below the 13.8x median of industry peers.
  • Our Market Compass rates the backdrop for Financials as favourable.
Threatsvaluation and setting
  • No specific threat is flagged by our checks; general market and interest-rate risk still applies.
Written by fixed rules from the figures on this page and the peer table below: filings, our fair value, the sector climate and the price trend. It summarises the data, it is not a forecast or advice.

Compare GL with peers and sector

Medians of 4 Life & Health Insurance peers and of 70 Financials stocks in our universe. Largest peers (X-Ray Score): MET 56, AFL 35, PFG 37, PFH 55.
MetricGLPeersSector
X-Ray Score (out of 100)494650
Valuation426352
Growth42954
Profitability584748
Financial health515250
Dividends484454

Sector leaders: highest X-Ray Score in Financials

GL ranks #44 of 71 in Financials and #3 of 5 in Life & Health Insurance by X-Ray Score. A higher score is stronger on our five pillars; it is a ranking of facts, not a forecast.
CompanyX-Ray Score
#1 PGR Progressive Corp69
#2 SCHW Schwab Charles Corp68
#3 AMP Ameriprise Financial Inc67
#4 AIZ Assurant, Inc.66
#5 PYPL PayPal Holdings, Inc.65
…
#44 GL Globe Life Inc. (this stock)49
Green means better than the peer median, red worse (only where a higher or lower figure is clearly better). A dash means too few companies report the figure. P/E, EV/EBITDA and price changes are not graded: a different level is not good or bad by itself.

Factor ratings for GL

Each factor is rated by where GL stands among the 71 Financials stocks in our universe.

Rating against the sector
Goodthe top third of these stocks
Averagethe middle third of these stocks
Badthe bottom third of these stocks
"Beats" is the share of those stocks it is ahead of.
Against its own history
The last columns set today's figure against the company's own median of its last five financial years:
▲ Betterbetter than its usual level
▼ Worseworse than its usual level
≈ In linewithin its usual range

For valuation factors Good means cheaper than most of the sector and Better means cheaper than usual for this company, which is not the same as a bargain.

In total: 1 Good · 5 Average · 2 Bad of 8 Growth: 0 · 1 · 2 Profitability: 0 · 2 · 0 Valuation: 1 · 2 · 0
FactorGLRatingSector medianOwn 5-year medianAgainst own history
Growth
Revenue growth, 3 years a year+4.7% Bad beats 27% +8.3% – –
Revenue growth, last year+3.7% Bad beats 23% +6.9% +4.2% ≈ In line
EPS growth, 3 years a year+15.9% Average beats 62% +12.7% – –
Profitability
Net margin19.6% Average beats 45% 21.8% 18.5% ≈ In line
Return on equity19.7% Average beats 66% 15.7% 21.6% ≈ In line
Valuation
P/E ratio11.0x Good beats 76% 13.8x 9.9x ≈ In line
Price / book2.2x Average beats 52% 2.2x 2.6x ▲ Better
Price / sales2.1x Average beats 64% 3.1x 1.9x ≈ In line
These ratings compare companies with each other and describe the past; they are not a forecast, a recommendation or part of the X-Ray Score. A factor is left out when its data is missing or meaningless (for example a P/E on negative earnings), and banks and insurers are rated only on the factors that apply to them. A dash in the history columns means fewer than three usable years.

Fundamentals checklist

● 3 Good · ● 6 Average · ● 4 Bad
Cash quality
Earnings backed by cashAverage
Free-cash-flow yieldGood
Risk models
Piotroski F-ScoreGood
Growth
EPS growth (3y)Average
Free-cash-flow growth (3y)Bad
Revenue growth (3y)Bad
Growth consistencyGood
Balance sheet
Net debt / EBITDAAverage
Interest coverBad
Valuation
Fair value vs priceBad
EBIT / EV yieldAverage
Profitability
Return on invested capitalAverage
Operating marginAverage
Each check is graded against the company's sector, not a fixed number. Checklist score 47/100.

Financials

FY21FY22FY23FY24FY25
Revenue$5.1B$5.2B$5.4B$5.8B$6.0B
Operating income$1.2B$1.2B$1.3B$1.5B$1.6B
Net income$1.0B$894M$971M$1.1B$1.2B
Operating cash flow$1.4B$1.4B$1.5B$1.4B$1.4B
Operating margin24.0%22.7%23.2%25.2%26.3%
Free cash flow$1.4B$1.4B$1.4B$1.3B$1.3B
Diluted EPS$9.99$9.04$10.07$11.94$14.07
Fiscal years, from SEC filings.

Technical summary

Daily
Bullish
8 bullish · 4 neutral · 4 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10167.5Bullish
EMA 10168.0Bullish
SMA 20166.6Bullish
EMA 20167.9Bullish
SMA 50170.3Bearish
EMA 50169.5Bearish
SMA 100172.5Bearish
EMA 100168.0Bullish
SMA 200158.7Bullish
EMA 200160.3Bullish
Oscillators (daily)
RSI (14)50.37Neutral
MACD (12, 26)-0.41Bearish
Momentum (12)1.28Bullish
Stochastic %K (14)72.45Neutral
Williams %R (14)-27.55Neutral
CCI (20)-15.78Neutral
Pivot points (classic, last session)
S3
156.7
S2
159.1
S1
163.8
Pivot
166.2
R1
170.8
R2
173.3
R3
177.9
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Dividends

Paid, last 12 months
1.26 USD
Yield on today's price
0.75%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend dateAmount per share
0.3300
0.3300
0.3300
0.2700
0.2700
0.2700
0.2700
0.2400
0.2400
0.2400
0.2400
0.2250
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.

ETFs that hold GL

ETFShare of the fund
KIE SPDR S&P Insurance1.97%
SPLV Invesco S&P 500 Low Volatility0.91%
DFAT DFA Investment Dimensions Group Inc.0.51%
SDY SPDR S&P Dividend0.47%
FMDE Fidelity Enhanced Mid Cap0.41%
VBR Vanguard Small-Cap Value0.30%
AVLV Avantis U.S. Large Cap Value0.25%
JHMM John Hancock Multifactor Mid Cap0.24%
The eight funds with the largest weight in GL among the ETFs we cover, from each fund's latest SEC Form N-PORT (quarter-end positions, so they can be months old). All ETFs.

GL stock splits

GL has split its stock 4 times since 1992. The latest was a 3-for-2 split on 2 Jul 2014.

Full GL stock split history →

GL SEC filings

8-KSEC EDGAR
Results of operations
8-KSEC EDGAR
Director or officer change
10-QSEC EDGAR
Quarterly report
8-KSEC EDGAR
Results of operations
8-KSEC EDGAR
Entered a material agreement
10-QSEC EDGAR
Quarterly report
8-KSEC EDGAR
Director or officer change; Shareholder vote results
8-KSEC EDGAR
Results of operations

Where the numbers come from

Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
Read the full methodology →

StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.